⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT March 10, 2026

Diproderm - dermatologische Lösung (Lösung zur Anwendung auf der Haut)

📷 Wikipedia: Betamethasone dipropionate · Source
Diproderm - dermatologische Lösung (Lösung zur Anwendung auf der Haut)
📷 Wikipedia: Betamethasone dipropionate · Source
Diproderm skin solution is temporarily unavailable due to manufacturing shortages. Supply is expected to resume on 28 May 2026.
⚠️
Shortage ongoing
BETAMETHASON DIPROPIONAT is currently in short supply in AT.
📈 Timeline
10 days active so far
May 18, 2026 May 27, 2026

What is this? Diproderm is a skin cream used to treat rashes and itching. It contains a mild steroid called betamethasone.

What's happening? There is no more Diproderm cream in stores right now. It will be back in May.

Does this affect me? If you use Diproderm, you may not be able to get it until May.

What should I do? Ask your pharmacist or doctor for another cream to use until then.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
BETAMETHASON DIPROPIONAT
Agency-published detail

🚫 Parallel export ban active · ATC: D07AC01 · Reason: Kapazitätsengpässe bei der Herstellung · Marketing authorisation holder: Organon Healthcare GmbH, Pestalozzistraße 31, 80469 München, Federal Republic of Germany · Affected packs: 1 Stück Schachtel, Flasche [Nicht verfügbar, since 2026-03-09, resupply 2026-06-30]

First published
March 10, 2026
Last refreshed by us
15 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Diproderm - dermatologische Lösung (Lösung zur Anwendung auf der Haut). Diproderm skin solution is temporarily unavailable due to manufacturing shortages. Supply is expected to resume on 28 May 2026.
▸ When was this alert issued?
This alert was issued on March 10, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.